Ask AI
lidERA
lidERA: Phase III Trial of Adjuvant Giredestrant vs Standard-of-Care Endocrine Therapy for ER+/HER2-Negative Early Breast Cancer

Released: December 15, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 15, 2025